Asset Management Corp T2 Biosystems, Inc. Call Options Transaction History

Asset Management Corp

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 21, 2022	BUY	$0.09 - $565.0 $4,365 - $27.4 Million	48,500 New	48,500 $5,000
Q4 2021 Jan 25, 2022	SELL	$0.46 - $0.94 $24,150 - $49,350	-52,500 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$1.32 - $3.79 $69,300 - $198,975	52,500 New	52,500 $85,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Asset Management Corp with notifications on news.